% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

  • wildbullus wildbullus Aug 1, 2013 4:47 PM Flag

    Z944 P1b will start soon!

    Advancing Z944, a novel oral T-type calcium channel (Cav 3.1-3.3) blocker, into further clinical development for the treatment of pain in the third quarter of 2013. The planned Phase 1b study is a state-of-the-art experimental clinical model utilizing Laser-Evoked-Potentials (LEP) to provide an efficient and objective assessment of the activity of Z944 in an induced neuropathic pain state. Results from the LEP study can further inform Zalicus’s development plans for Z944 in a variety of potential pain indications.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies